
Xultophy
My Prescription
Payment
Select pharmacy




$256.36
$15.00 due at pharmacy
$256.36 - $15.00 = $241.36
$241.36 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
$256.36
Print or send this coupon to your phone
About Xultophy
Drug Details
Xultophy is a medication designed to help adults with Type 2 diabetes effectively manage their blood sugar levels. It combines two active ingredients: insulin degludec, a long-acting insulin, and liraglutide, a glucagon-like peptide-1 (GLP-1) agonist. This combination works by providing a steady level of insulin to help glucose enter cells for energy and by stimulating insulin release in response to high blood sugar levels, while reducing sugar production by the liver. Xultophy is most effective when used alongside a balanced diet and regular exercise. Administered as a once-daily injection using a prefilled pen, it can help prevent complications such as kidney damage, blindness, nerve issues, limb loss, and problems with sexual function. Additionally, maintaining proper blood sugar control with Xultophy may reduce the risk of heart attack or stroke. Common side effects may include low blood sugar, cold-like symptoms, and headache. Always consult with your healthcare provider for personalized medical advice.
Price history for Xultophy
1, 3ML of 100-3.6UNIT-MG/ML
Average retail price for Xultophy
Average SaveHealth price for Xultophy
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Xultophy dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 3ML of 100-3.6UNIT-MG/ML | 1 Pen | $256.36 | $256.36 |
| 3ML of 100-3.6UNIT-MG/ML | 2 Pens | $507.71 | $253.86 |
| 3ML of 100-3.6UNIT-MG/ML | 3 Pens | $759.07 | $253.02 |
Xultophy FAQs
Xultophy contains insulin degludec, which is a long-acting insulin.
Xultophy is not primarily associated with weight loss. It is a combination medication used to improve blood sugar control in adults with type 2 diabetes. While some patients may experience weight changes, weight loss is not a common effect of Xultophy. Patients should discuss any concerns about weight changes with their healthcare provider.
Xultophy and Tresiba are not the same. Xultophy is a combination medication that contains insulin degludec (Tresiba) and liraglutide, a GLP-1 receptor agonist. Tresiba, on the other hand, contains only insulin degludec. They are used for managing diabetes but have different compositions and mechanisms of action.
Xultophy is a combination of insulin degludec and liraglutide. Insulin degludec, a long-acting insulin, is comparable to other long-acting insulins such as insulin glargine (found in Lantus or Toujeo) and insulin detemir (found in Levemir). However, Xultophy also contains liraglutide, a GLP-1 receptor agonist, which makes it unique. There is no direct single insulin product that is entirely comparable to Xultophy due to this combination.
Xultophy is a medication that combines insulin degludec and liraglutide. While its primary use is to improve blood sugar control in adults with type 2 diabetes, some patients may experience weight loss as a side effect due to the liraglutide component, which can reduce appetite. However, weight changes can vary among individuals, and it is important to follow a healthcare provider's guidance for managing weight and diabetes.